Cargando…

QT Interval Prolongation in People Treated With Bedaquiline for Drug-Resistant Tuberculosis Under Programmatic Conditions: A Retrospective Cohort Study

BACKGROUND: Bedaquiline has a black-box warning of the risk of arrhythmias and sudden death. This study aimed to determine the incidence of QTc prolongation and cardiac events in patients receiving bedaquiline for drug-resistant tuberculosis (DR-TB) under programmatic conditions. METHODS: Retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isralls, Sharon, Baisley, Kathy, Ngam, Eric, Grant, Alison D, Millard, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403230/ https://www.ncbi.nlm.nih.gov/pubmed/34466629 http://dx.doi.org/10.1093/ofid/ofab413

Ejemplares similares

Safety of prolonged treatment with bedaquiline in programmatic conditions
por: Zhurkin, Dzmitriy, et al.
Publicado: (2022)

Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens
por: Tanneau, Lénaïg, et al.
Publicado: (2022)

Effects of Bedaquiline Combined with Fluoroquinolone and/or Clofazimine on QT Interval in Patients with Multidrug-Resistant Tuberculosis: a Retrospective Study
por: Li, Rong, et al.
Publicado: (2023)

Bedaquiline, Delamanid, Linezolid, and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis
por: Padmapriyadarsini, Chandrasekaran, et al.
Publicado: (2022)

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023)

Beyond a prolonged QT interval
por: Bitar, Zouheir Ibrahim, et al.
Publicado: (2013)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Bedaquiline for multidrug-resistant tuberculosis and QTc prolongation in California
por: Katrak, Shereen, et al.
Publicado: (2021)

Prevalence and Risk Factors for Mycobacterium tuberculosis Infection Among Adolescents in Rural South Africa
por: Mzembe, Themba, et al.
Publicado: (2020)

Multifactorial QT Interval Prolongation and Takotsubo Cardiomyopathy
por: Gysel, Michael, et al.
Publicado: (2014)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Azithromycin: QT interval prolongation: case report
Publicado: (2021)

Chloroquine: QT interval prolongation: case report
Publicado: (2021)

Prolonged QT Interval in Cirrhosis: Twisting Time?
por: Lee, William, et al.
Publicado: (2022)

Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
por: Nimmo, Camus, et al.
Publicado: (2020)

Model-Predicted Impact of ECG Monitoring Strategies During Bedaquiline Treatment
por: van Beek, Stijn W, et al.
Publicado: (2022)

Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort( )
por: Hewison, Catherine, et al.
Publicado: (2022)

Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study
por: Brust, James C M, et al.
Publicado: (2021)

Prolonged QT interval in a man with anorexia nervosa
por: Macías-Robles, María Dolores, et al.
Publicado: (2009)

Correlation between seizure in children and prolonged QT interval
por: Sadrnia, Saeid, et al.
Publicado: (2013)

Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update
por: Niemeijer, Maartje N., et al.
Publicado: (2015)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

QT Interval Prolongation in Patients with Systemic Sclerosis—Are the Holter ECG Recordings a Better Option for QT Interval Evaluation?
por: Saramet, Elena E., et al.
Publicado: (2021)

QT-interval prolongation due to medication found in the preoperative evaluation
por: Seto, Mika, et al.
Publicado: (2017)

Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2021)

Prognostic significance of prolonged corrected QT interval in cerebral contusion
por: Yavuz, Ahmed Yasin, et al.
Publicado: (2023)

Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
por: Ninkovic, Vladan M., et al.
Publicado: (2016)

Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs( )
por: Huerga, Helena, et al.
Publicado: (2022)

QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies
por: Ali, Ali Mohamed, et al.
Publicado: (2023)

Pseudo-colouring an ECG enables lay people to detect QT-interval prolongation regardless of heart rate
por: Alahmadi, Alaa, et al.
Publicado: (2020)

Dabigatran Does Not Prolong the QT Interval with Supratherapeutic Exposure: a Thorough QT Study in Healthy Subjects
por: Ring, Arne, et al.
Publicado: (2013)

Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India
por: Hoffman, Seth A, et al.
Publicado: (2023)

QT interval prolongation after sertraline overdose: a case report
por: de Boer, Rudolf A, et al.
Publicado: (2005)

High incidence of severely prolonged QT interval after cardiac surgery
por: Biry, M, et al.
Publicado: (2010)

Severe QT interval prolongation associated with moxifloxacin: a case report
por: Koide, Tetsuro, et al.
Publicado: (2008)

Evaluation of Ondansetron-induced QT interval prolongation in the prophylaxis of postoperative emesis
por: Gupta, Sampa Dutta, et al.
Publicado: (2011)

Does Artesunate Prolong the Electrocardiograph QT Interval in Patients with Severe Malaria?
por: Maude, Richard J., et al.
Publicado: (2009)

Prolonged Corrected QT Interval in Patients with Myotonic Dystrophy Type 1
por: Park, Kang Min, et al.
Publicado: (2013)

Editorial: Safety Pharmacology – Risk Assessment QT Interval Prolongation and Beyond
por: Grandi, Eleonora, et al.
Publicado: (2018)

Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand
por: Waleekhachonloet, Onanong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7t7t3qgjt8iogflr57ubit624h